In a bid to accelerate vaccination against COVID-19 in rural areas and small towns of the country, Pune-based vaccine maker Serum Institute of India (SII) has entered into a partnership with the industry body Confederation of Indian Industry (CII), reports Hindustan Times.
SII's chief executive Adar Poonawalla said that the partnership “will be a good way to close the gaps” as there is plenty of supply of Covishield doses available for distribution. He emphasised that it is essential that all stakeholders work together towards carrying out vaccinations.
CII's president TV Narendran said that the partnership with SII will help in catalysing the industry participation to reach out to the communities at large. He said that CII aims to connect community, hospital and corporates to fast-track vaccinations.
CII is also mapping the state-wise vaccination requirement and setting up inoculation camps focusing on reaching rural areas and second and third-tier cities.
Meanwhile, it should be noted that other than SII's Covishield, India is also using Bharat Biotech's Covaxin and Russian Sputnik V COVID-19 vaccines for nationwide inoculation drive.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.